India Pharmaceutical Contract Sales Organizations Market Size, Share & Trends Analysis Report By Service (Personal, Non-personal Promotion), By End-use (Pharmaceutical Companies, Biopharmaceutical Companies), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. End-use
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in India
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Service outlook
  • 2.2.2. End Use outlook
• 2.3. Competitive Insights

Chapter 3. India Pharmaceutical Contract Sales Organizations Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing pharmaceutical outsourcing trends
    • 3.2.1.2. Increased pharmaceutical industry complexity
    • 3.2.1.3. Enhanced sales force effectiveness
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Data security and privacy concerns
    • 3.2.2.2. Dependency on client companies
• 3.3. India Pharmaceutical Contract Sales Organizations Market Analysis Tools
  • 3.3.1. Industry analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. India Pharmaceutical Contract Sales Organizations Market: Service Business Analysis

• 4.1. India Pharmaceutical Contract Sales Organizations Market, By Service: Segment Dashboard
• 4.2. India Pharmaceutical Contract Sales Organizations Market, By Service: Movement Analysis
• 4.3. India Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts, By Service, 2018 - 2030
  • 4.3.1. Personal Promotion
    • 4.3.1.1. India Personal Promotion Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
    • 4.3.1.2. Promotional Sales Team
    • 4.3.1.2.1 India Promotional Sales Team Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
    • 4.3.1.3. Key Account Management
    • 4.3.1.3.1 India Key Account Management Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
    • 4.3.1.4. Vacancy Management
    • 4.3.1.4.1 India Vacancy Management Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
  • 4.3.2. Non-personal Promotion
    • 4.3.2.1. India Non-personal Promotion Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
    • 4.3.2.2. Medical Affairs Solutions
    • 4.3.2.2.1 India Medical Affairs Solutions Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
    • 4.3.2.3. Remote Medical Science Liaisons
    • 4.3.2.3.1. India Remote Medical Science Liaisons Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
    • 4.3.2.4. Nurse (Clinical) Educators
    • 4.3.2.4.1. India Nurse (Clinical) Educators Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
    • 4.3.2.5. Others
    • 4.3.2.5.1. India Others Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)

Chapter 5. India Pharmaceutical Contract Sales Organizations Market: End-use Business Analysis

• 5.1. India Pharmaceutical Contract Sales Organizations Market, By End-use: Segment Dashboard
• 5.2. India Pharmaceutical Contract Sales Organizations Market, By End-use: Movement Analysis
• 5.3. India Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts, By End-use, 2018 - 2030
  • 5.3.1. Pharmaceutical Companies
    • 5.3.1.1. India Pharmaceutical Companies Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
  • 5.3.2. Biopharmaceutical Companies
    • 5.3.2.1. India Biopharmaceutical Companies Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis by Key Market Participants
• 6.2. Company Heat Map Analysis
• 6.3. Company Categorization
• 6.4. Strategy Mapping
  • 6.4.1. Merger& Acquisition
  • 6.4.2. Collaborations
  • 6.4.3. New Product Launch
• 6.5. Participant's overview
  • 6.5.1. IQVIA Inc.
    • 6.5.1.1. Overview
    • 6.5.1.2. Financial Performance
    • 6.5.1.3. Product Benchmarking
    • 6.5.1.4. Strategic Initiatives
  • 6.5.2. Syneos Health
    • 6.5.2.1. Overview
    • 6.5.2.2. Financial Performance
    • 6.5.2.3. Product Benchmarking
    • 6.5.2.4. Strategic Initiatives
  • 6.5.3. Parexel International (MA) Corporation
    • 6.5.3.1. Overview
    • 6.5.3.2. Financial Performance
    • 6.5.3.3. Product Benchmarking
    • 6.5.3.4. Strategic Initiatives
  • 6.5.4. Mednext Pharma Private Limited
    • 6.5.4.1. Overview
    • 6.5.4.2. Financial Performance
    • 6.5.4.3. Product Benchmarking
    • 6.5.4.4. Strategic Initiatives
  • 6.5.5. Indegene
    • 6.5.5.1. Overview
    • 6.5.5.2. Financial Performance
    • 6.5.5.3. Product Benchmarking
    • 6.5.5.4. Strategic Initiatives
  • 6.5.6. ICON plc
    • 6.5.6.1. Overview
    • 6.5.6.2. Financial Performance
    • 6.5.6.3. Product Benchmarking
    • 6.5.6.4. Strategic Initiatives
  • 6.5.7. PPD (Thermo Fisher Scientific Inc.)
    • 6.5.7.1. Overview
    • 6.5.7.2. Financial Performance
    • 6.5.7.3. Product Benchmarking
    • 6.5.7.4. Strategic Initiatives
  • 6.5.8. QFR Solutions
    • 6.5.8.1. Overview
    • 6.5.8.2. Financial Performance
    • 6.5.8.3. Product Benchmarking
    • 6.5.8.4. Strategic Initiatives
  • 6.5.9. LabCorp
    • 6.5.9.1. Overview
    • 6.5.9.2. Financial Performance
    • 6.5.9.3. Product Benchmarking
    • 6.5.9.4. Strategic Initiatives
  • 6.5.10. Makrocare
    • 6.5.10.1. Overview
    • 6.5.10.2. Financial Performance
    • 6.5.10.3. Product Benchmarking
    • 6.5.10.4. Strategic Initiatives

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 India Pharmaceutical Contract Sales Organizations Market by Service, 2018 - 2030 (USD Million)
• Table 4 India Pharmaceutical Contract Sales Organizations Market by End-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Pharmaceutical Contract Sales Organizations Market, Market Segmentation
• Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 10 Penetration & Growth Prospect Mapping
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
• Fig. 14 Regional Marketplace: Key Takeaways
• Fig. 15 India Pharmaceutical Contract Sales Organizations Market for Personal Promotion, 2018 - 2030 (USD Million)
• Fig. 16 India Pharmaceutical Contract Sales Organizations Market for Promotional sales team, 2018 - 2030 (USD Million)
• Fig. 17 India Pharmaceutical Contract Sales Organizations Market for Key account management, 2018 - 2030 (USD Million)
• Fig. 18 India Pharmaceutical Contract Sales Organizations Market for Vacancy Management, 2018 - 2030 (USD Million)
• Fig. 19 India Pharmaceutical Contract Sales Organizations Market for Non-personal promotion, 2018 - 2030 (USD Million)
• Fig. 20 India Pharmaceutical Contract Sales Organizations Market for Medical affairs solutions, 2018 - 2030 (USD Million)
• Fig. 21 India Pharmaceutical Contract Sales Organizations Market for Remote medical science liaisons, 2018 - 2030 (USD Million)
• Fig. 22 India Pharmaceutical Contract Sales Organizations Market for Nurse (clinical) educators, 2018 - 2030 (USD Million)
• Fig. 23 India Pharmaceutical Contract Sales Organizations Market for Others, 2018 - 2030 (USD Million)
• Fig. 24 India Pharmaceutical Contract Sales Organizations Market for Pharmaceutical companies, 2018 - 2030 (USD Million)
• Fig. 25 India Pharmaceutical Contract Sales Organizations Market for Biopharmaceutical companies, 2018 - 2030 (USD Million)